Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study

Figure 1

ELISA for four candidate proteins in plasma samples from CRC patients and healthy controls. (a) Plasma samples from 32 CRC patients and 32 healthy controls were used in this study. All values are shown on figures. (b) Extended verification of ELISA of BST2 and TROP2 in another plasma sample set containing 120 CRC patients and 120 healthy controls.

(a)

(b)